Join us for our next dystonia support group meeting.
Individuals with all forms of dystonia, family and friends are welcome.
August 10, 2026
7:00 pm ET – 8:00 pm ET
Guest Speaker:
Michael Oldham, MD, MPH
Vice President of Clinical Development at Vima Therapeutics and a board-certified neurologist with special qualifications in child neurology and epilepsy.
Dr. Oldham supports the strategy and implementation of Vima’s lead programs and will provide general information about clinical research, and discuss Stride Dystonia, the current phase 2 study for the first oral medication for dystonia.
Vima Therapeutics is a Team of doctors, scientists, and experts and movement disorders who are united by a shared mission to advance a new era in treatments for movement disorder. Vima Therapeutics is currently conducting a phase two study for the first oral medication for dystonia. You can find out more at www.stridedystonia.com or www.vimatx.com.
We look forward to seeing you.
If you are interested in attending, please reach out to DMRF support group leader Bill Aemisegger at 586-232-5028 or ad***@******************ia.com for login details.
Group Webpage: https://www.metrodetroitdystonia.com/
Group Facebook Page: https://www.facebook.com/groups/563614013751215